Ein Unternehmen der RHÖN-KLINIKUM AG

Univ.-Prof. Dr. med. Johannes Kruse

Direktor der Klinik Tel.: 0641/985-45600 johannes.kruse@psycho.med.uni-giessen.de

Beruflicher Lebenslauf      

seit 05/2011 Direktor der Klinik für Psychosomatische Medizin und Psychotherapie Universitätsklinikums Gießen und Marburg (UKGM), Marburg
seit 05/2009 Universitätsprofessor an der Justus-Liebig-Universität Gießen und Direktor der Klinik für Psychosomatik und Psychotherapie Universitätsklinikums Gießen und Marburg (UKGM), Gießen
2001  Habilitation
1996-2009 Stellvertretender Direktor der Klinik für Psychotherapeutische Medizin der Heinrich-Heine-Universität Düsseldorf
1991-1996 Wissenschaftlicher Assistent (C1) an der Klinik für Psychosomatische Medizin und Psychotherapie der Heinrich-Heine-Universität Düsseldorf
1988 Promotion
1984-1985 Assistenzarzt an der Psychiatrischen Klinik der Rheinischen Landesklinik Viersen

Facharzt für Psychosomatische Medizin und Psychotherapie, Psychoanalyse, Psychotraumatologie, EMDR

Forschungsschwerpunkte:

  • Psychische Störungen bei körperlichen Erkrankungen
  • Klinische Studien
  • Psychotraumatologie
  • Somatoforme Störungen

Ämter:

  • Vorsitzender der Deutschen Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)
  • Sprecher der Ständigen Konferenz ärztlicher psychotherapeutischer Verbände (STÄKO)
  • Mitglied im Wissenschatlichen Beirat Psychotherapie
  • Leitung des Arbeitsausschusses "Psychische Gesundheit" des Gemeinsamen Landesgremiums nach §90a SGB V

Preise und Auszeichnungen:

  • 2003 Römer-Preis des Deutschen Kollegiums für Psychosomatische Medizin und Psychotherapie
  • 2011 Heigl Preis der Heigl Stiftung

Ausgewählte Publikationen:

2021

Atasoy S, Johar H, Herder C, Rathmann W, Koenig W, Roden M, Peters A, Kruse J, Ladwig KH (2021): Generalized anxiety disorder symptoms and type 2 diabetes onset: Findings from the Prospective Cooperative Health Research in the Region of Augsburg F4 and FF4 studies. J Psychosom Res 145: 110480.

Brüne M, Linnenkamp U, Andrich S, Jaffan-Kolb L, Claessen H, Dintsios M, Schmitz-Losem I, Kruse J, Chernyak N, Hiligsmann M, Hermanns N, Icks A (2021): Healthcare utilization and costs in individuals with diabetes with and without comorbid depression in Germany: Results of the cross-sectional DiaDec Study. Diabetes Care 44(2): 407-415.

Cuntz U, Brückner-Bozetti P, Hochlehnert A, Friederich H-C, Kruse J, Heuft G, Hildenbrand G, Sauer N, Kölch M, Löhr M, Hauth I (2021): Treatment clusters and personnel assessment in psychosomatic medicine and psychotherapy - results of a feasibility study of the platform model. Z Psychosom Med Psychother 67(1): 88-103.

Ertle CM, Rommel FR, Tumala S, Moriwaki Y, Klein J, Kruse J, Gieler U, Peters EMJ (2021): New Pathways for the Skin’s Stress Response: The Cholinergic Neuropeptide SLURP-1 Can Activate Mast Cells and Alter Cytokine Production in Mice. Front. Immunol. doi: 10.3389/fimmu.2021.631881. Online ahead of print.

Fleischer T, Ulke C, Beutel M, Binder H, Brähler E, Johar H, Atasoy S, Kruse J, Otten D, Tibubos AN, Zöller D, Speerforck S, Grabe HJ, Ladwig K-H, Schomerus G (2021): The relation between childhood adversity and adult obesity in a populationbased study in women and men. Scientific Reports 11: 14068.

Freier A, Kruse J, Schmalbach B, Zara S, Werner S, Brähler E, Fegert JM, Kampling H (2021): The mediation effect of personality functioning between different types of child maltreatment and the development of depression/anxiety symptoms -A German representative study. J Affect Disord 299: 408-415.

 

Humer E, Sattel H, Gündel H, Henningsen P, Kruse J, Schneider G, Lahmann C, Pieh C, Probst T (2021): Stress, depression, and the therapeutic alliance as mediators on the outcome of brief psychodynamic-interpersonal psychotherapy for multisomatoform disorder. Psychother Res 31(8): 1012-1021.


Icks A, Wittgens C, Haastert B, Jöckel K-H, Engel M, Erbel R, Andrich S, Kruse J, Kulzer B, Hermanns N, Herder C, Moebus S, Stang A, Kowall B (2021): High Depressive Symptoms in Previously Undetected Diabetes – 10-Year Follow-Up Results of the Heinz Nixdorf Recall Study. Clinical Epidemiology 13: 429–438.


Johar H, Spieler D, Bidlingmaier M, Herder C, Rathmann W, Koenig W, Peters A, Kruse J, Ladwig K-H (2021): Chronic Inflammation Mediates the Association between Cortisol and Hyperglycemia: Findings from the Cross-Sectional Population-Based KORA Age Study. J. Clin. Med. 10, 2751. 

 

Kulzer B, Albus C, Herpertz S, Kruse J, Lange K, Lederbogen F, Petrak F (2021): Psychosocial Factors and Diabetes. Exp Clin Endocrinol Diabetes 129(S 01): 91-105.

 

Nübel J, Truthmann J, Heidemann C, Du Y, Paprott R, Hapke U, Kruse J, Scheidt-Nave C, Baumert J (2021): Sex-specific impact of major depressive disorder on 12-year change in glycaemic status: Results from a nationwide cohort study of adults without diabetes in Germany. Diabet Med. Online ahead of print.

 

Otten D, Tibubos AN, Schomerus G, Brähler E, Binder H, Kruse J, Ladwig K-H,
Wild PS, Grabe HJ, Beutel ME (2021): Similarities and Differences of Mental Health in Women and Men: A Systematic Review of Findings in Three Large German Cohorts. Front. Public Health 9: 553071. 

 

Poß-Doering R, Hegelow M, Borchers M, Hartmann M, Kruse J, Kampling H, Heuft G, Spitzer C, Wild B, Szecsenyi J, Friederich H-C (2021): Evaluating the structural reform of outpatient psychotherapy in Germany (ES-RiP trial) - a qualitative study of provider perspectives. BMC Health Serv Res 21(1): 1294.


Puls H-C, Schmidt R, Zenger M, Kampling H, Kruse J, Brähler E, Hilbert A (2021): Sex-Specific Mediation Effects of Workplace Bullying on Associations between Employees’ Weight Status and Psychological Health Impairments.
Nutrients 13(11): 3867.

 

Tibubos AN, Otten D, Zöller D, Binder H, Wild PS, Fleischer T, Johar H, Atasoy S, Schulze L, Ladwig K-H, Schomerus G, Linkohr B, Grabe HJ, Kruse J, Schmidt C-O, Münzel T, König J, Brähler E, Beutel ME (2021): Bidimensional structure and measurement equivalence of the Patient Health Questionnaire-9: sex-sensitive assessment of depressive symptoms in three representative German cohort studies. BMC Psychiatry 21(1): 238. 

 

 
2020

Burghardt J, Tibubos AN, Otten D, Brähler E, Binder H, Grabe H, Kruse J, Ladwig KH, Schomerus G, Wild PS, Beutel ME (2020): A multi-cohort consortium for GEnder-Sensitive Analyses of mental health trajectories and implications for prevention (GESA) in the general population in Germany. BMJ Open 10(2):e034220. doi: 10.1136/bmjopen-2019-034220.
 
Jiang L, Atasoy S, Johar H, Herder C, Peters A, Kruse J, Ladwig KH (2020): Anxiety boosts progression of prediabetes to type 2 diabetes: findings from the prospective Cooperative Health Research in the Region of Augsburg F4 and FF4 studies.Diabet Med. 37(10): 1737-1741. doi: 10.1111/dme.14232.
 
Ladwig KH, Schriever SC, Atasoy S, Bidlingmaier M, Kruse J, Johar H (2020): Association of generalized and central obesity with serum and salivary cortisol secretion patterns in the elderly: findings from the cross sectional KORA-Age study. Sci Rep 10(1): 14321. doi: 10.1038/s41598-020-71204-6.
 
Linnenkamp U, Gontscharuk V, Brüne M, Chernyak N, Kvitkina T, Arend W, Fiege A, Schmitz-Losem I, Kruse J, Evers SMAA, Hiligsmann M, Hoffmann B, Andrich S, Icks A (2020): Using statutory health insurance data to evaluate non-response in a cross-sectional study on depression among patients with diabetes in Germany.Int J Epidemiol 49(2): 629-637. doi: 10.1093/ije/dyz278.
 
Mulfinger N, Lampl J, Dinkel A, Weidner K, Beutel M, Jarczok M, Hildenbrand G, Kruse J, Seifried-Dübon T, Junne F, Beschoner P, Gündel H (2020): Psychische Belastungen durch Epidemien bei Beschäftigten im Gesundheitswesen und Impli-kationen für die Bewältigung der Corona-Krise: eine Literaturübersicht.Z Psychosom Med Psychother 66(3): 220-242. doi: 10.13109/zptm.2020.66.3.220.
 
Stingl M, Hanewald B, Kruse J, Sack M (2020): Positive Side Effects in Trauma-Focusing PTSD Treatment: Reduction of Attendant Symptoms and Enhancement of Affective and Structural Regulation. Psychological Trauma: Theory, Research, Practice and Policy. Online ahead of print. doi: 10.1037/tra0000700.
 
2019

Brock J, Schmid A, Karrasch T, Pfeferle P, Schlegel J, Busse I, Hauenschild A, Schmidt B, Koukou M, Arapogianni E, Schultz A, Thomalla M, Akinci S, Kruse J, Padberg W, Schäffler A, Albrecht J (2019): Progranulin serum levels and gene expression in subcutaneous vs visceral adipose tissue of severely obese patients undergoing bariatric surgery. Clin Endocrinol (Oxf) 91(3): 400-410.
doi: 10.1111/cen.14040
 
Kolb-Niemann B, Kruse J (2019): Bedeutung der psychosomatischen Medizin für Menschen mit seltenen Erkrankungen. Internist 60(6): 638-643
doi: 10.1007/s00108-019-0613-8
 
Leichsenring F, Abbass A, Beutel M, Gündel H, Heuft G, Hoffman SO, Kächele H, Kruse J, Rüger U, Rudolf G, Spitzer C, Salzer S, Luyten P, Wampold B, Steinert C (2019): Vom Sinn des Verfahrenskonzepts und der Verfahrensvielfalt – und warum das Baukasten-System in der Psychotherapie nicht funktioniert. Z Psychosom Med Psychother 65(4): 321-340. doi: 10.13109/zptm.2019.65.4.oa1
 
Steinert C, Kruse J, Leweke F, Leichsenring F (2019): Psychosomatic inpatient treatment: Real-world effectiveness, response rates and the helping alliance.J Psychosom Res 124:109743. doi: 10.1016/j.jpsychores.2019.109743
 
    

2018

Atasoy S, Johar H, Fang XY, Kruse J, Ladwig KH (2018): Cumulative effect of depressed mood and obesity on type II diabetes incidence: Findings from the MONICA/KORA cohort study. J Psychosom Res 115: 66-70
doi: 10.1016/j.jpsychores.2018.10.007

Emeny RT, Baumert J, Zannas AS, Kunze S, Wahl S, Lurato S, Arloth J, Erhardt A, Balsevich G, Schmidt MV, Weber P, Kretschmer A, Pfeiffer L, Kruse J, Strauch K, Roden M, Herder C, Koenig W, Gieger C, Waldenberger M, Peters A, Binder EB, Ladwig KH (2018): Anxiety Associated Increased CpG Methylation In The Promoter of Asb1: A Translational Approach Evidenced By Epidemiological And Clinical Studies And A Murine Model. Neuropsychopharmacology 43(2): §42-353.
doi: 10.1038/npp.2017.102

   

Jelenik T, Dille M, Müller-Lühlhoff S, Kabra DG, Zhou Z, Binsch C, Hartwig S, Lehr S, Chadt A, Peters EMJ, Kruse J, Roden M, Al-Hasani H, Castañeda TR (2018): FGF21 regulates insulin sensitivity following long-term chronic stress. Mol Metab. 16: 126-138. doi: 10.1016/j.molmet.2018.06.012

   

Peters EMJ, Müller Y, Snaga W, Fliege H, Reißhauer A, Schmidt-Rose T, Max H, Schweiger D, Rose M, Kruse J (2017): Hair and stress: A pilot study of hair and cytokine balance alteration in healthy young women under major exam stress.

PLoS One 12(4): e0175904. doi: 10.1371/journal.pone.0175904. eCollection 2017

 

Steinert C, Bumke PJ, Hollekamp RL, Larisch A, Leichsenring F, Mattheß H, Sek S, Sodemann U, Stingl M, Ret T, Vojtová H, Wöller W, Kruse J (2017): Resource activation for treating post-traumatic stress disorder, co-morbid symptoms and impaired functioning: a randomized controlled trial in Cambodia. Psychol Med 47(3): 553-564. doi: 10.1017/S0033291716002592. Epub 2016 Nov 2.

   

2016

Johar H, Emeny RT, Bidlingmaier M, Kruse J, Ladwig KH (2016): Sex-related differences in the association of salivary cortisol levels and type 2 diabetes. Findings from the cross-sectional population based KORA-age study. Psychoneuro­endocrinology 69: 133-141. doi: 10.1016/j.psyneuen.2016.04.004

 

Jünger J, Köllner V, von Lengerke T, Neuderth S, Schultz JH, Fischbeck S, Karger A, Kruse J, Weidner K, Henningsen P, Schiessl C, Ringel N, Fellmer-Drüg E (2016): Competence-based catalogue of learning objectives for conducting medical consultations. Z Psychosom Med Psychother 62(1): 5-19

doi: 10.13109/zptm.2016.62.1.5

 

Lukaschek K, von Schacky C, Kruse J, Ladwig KH (2016): Cognitive Impairment Is Associated with a Low Omega-3 Index in the Elderly: Results from the KORA-Age Study. Dement Geriatr Cogn Disord 42(3-4): 236-245 (IF 3.408)

 

Lukaschek K, Baumert J, Kruse J, Ladwig KH (2016): The Association of Social Inhibition and Posttraumatic Stress Disorder: A Vicious Circle?: Results From the Population-Based KORA F4 Study With 1232 Participants With Trauma Exposure.

J Nerv Ment Dis 204(4): 261-266. doi: 10.1097/NMD.0000000000000468

 

Nolte S, van der Mei SH, Strehl-Schwarz K, Köster J, Bender A, Rose M, Kruse J, Peters EMJ (2016): Comparison of patient-reported need of psycho-oncologic support and the doctor’s perspective: how do they relate to disease severity in melanoma patients? Psychooncology 25(11): 1271-1277. doi.1002/pon.4050

 

Sack M, Zehl S, Otti A, Lahmann C, Henningsen P, Kruse J, Stingl M (2016): A Comparison of Dual Attention, Eye Movements, and Exposure Only during Eye Movement Desensitization and Reprocessing for Posttraumatic Stress Disorder: Results from a Randomized Clinical Trial. Psychother Psychosom 85(6): 357-365

 

 

Steinert C, Bumke PJ, Hollekamp RL, Larisch A, Leichsenring F, Mattheß H, Sisokhom S, Sodemann U, Stingl M, Thearom R, Vojtová H, Wöller W, Kruse J (2016): Treating post-traumatic stress disorder by resource activation in Cambodia. World Psychiatry 15(2): 183-185 (IF 20.205)

 

Steinert C, Kruse J, Leichsenring F (2016): Long-term outcome and non-response in psychotherapy: Are we short-sighted? Psychother Psychosom 85(4): 235-237  
(IF 7.632)

 

Hermanns N, Schmitt A, Gahr A, Herder C, Nowotny B, Roden M, Ohmann C, Kruse J, Haak T, Kulzer B. (2015): The effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial. Diabetes Care, 38(4), 551-60

 

Heuft G, Hochlehnert A, Barufka S, Nikendei C, Kruse J, Zipfel S, Hofmann T, Hildenbrand G, Cuntz U, Herzog W, Heller M. (2015): Normative-empirical determination of personnel requirements in psychosomatic medicine and psychotherapy. Z Psychosom Med Psychother., 61(4), 384-98. doi: 10.13109/zptm.2015.61.4.384. German.

 

Steinert C, Hofmann M, Leichsenring F, Kruse J (2015): The course of PTSD in naturalistic long-term studies: High variability of outcomes. A systematic review. Nord J Psychiatry., 69(7), 483-96